Metrikler
Yayın
198
Açık Erişim
62
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1984 - 1989
1984 - 1989Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
Araştırma Alanları
Tıp
Akademik Ünvanlar / Görevler
1998 - Devam Ediyor
1998 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2000 - 2006
2000 - 2006Dekan Yardımcısı
Hacettepe Üniversitesi, Tıp Fakültesi
Akademi Dışı Deneyim
1984 - 1989
1984 - 1989Araştırma Görevlisi
Hacettepe Üniversitesi Tıp Fakültesi, Araştırma Görevlisi
1983 - 1984
1983 - 1984Pratisyen hekim
SSK bayrampaşa Dispanseri, Pratisyen hekim
1982 - 1983
1982 - 1983Cezaevi hekimi
Adalet Bakanlığı Çankırı Kapalı Cezaevi Tabipliği, Cezaevi hekimi
Makaleler
Tümü (159)
SCI-E, SSCI, AHCI (142)
SCI-E, SSCI, AHCI, ESCI (153)
ESCI (10)
Scopus (149)
TRDizin (19)
2025
20251. Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Turkiye
Ocakli A. I., Ozyar-Kurtcu S. A., Uzun M., KAŞIKCI ÇAVDAR M., Telli-Dizman G., METAN G., et al.
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY
, cilt.7, sa.2, ss.156-165, 2025 (ESCI, TRDizin)
2025
20252. Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project
Moreno-Mellado E., ASLAN A. T., AKOVA M., Leon E., Merchante N., Vinuesa D., et al.
CLINICAL MICROBIOLOGY AND INFECTION
, sa.5, ss.839-846, 2025 (SCI-Expanded, Scopus)
2025
20253. Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)
Pagano L., Maschmeyer G., Lamoth F., Blennow O., Xhaard A., Spadea M., et al.
LEUKEMIA
, 2025 (SCI-Expanded, Scopus)
2025
20254. Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database
Gajdos L., Buetti N., Tabah A., Ruckly S., AKOVA M., Sjoval F., et al.
INTENSIVE CARE MEDICINE
, 2025 (SCI-Expanded, Scopus)
2025
20255. Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatment
BOŞNAK C., AKOVA M.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
, 2025 (SCI-Expanded)
2025
20256. Incorporating ethics into infectious disease clinical practice guidelines
Righi E., Yahav D., Nasim A., AKOVA M., Barac A., Scudeller L., et al.
CLINICAL MICROBIOLOGY AND INFECTION
, sa.4, ss.560-567, 2025 (SCI-Expanded, Scopus)
2025
20257. Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study
Aslan A. T., KARA E., Koksal G., Bilir Y., Saracoglu K. T., ESER F., et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
, sa.3, 2025 (SCI-Expanded, Scopus)
2025
20258. Infectious diseases ethics: a worldwide survey
Righi E., Mirandola M., Grossi A. A., AKOVA M., Tacconelli E., Fratucello A., et al.
CLINICAL MICROBIOLOGY AND INFECTION
, sa.2, ss.282-289, 2025 (SCI-Expanded, Scopus)
2025
20259. Prevention and treatment of bacterial infections in patients with haematological cancers and haematopoietic stem cell transplantation: headways and shortcomings
ER A. G., Aslan A. T., Mikulska M., AKOVA M.
CLINICAL MICROBIOLOGY AND INFECTION
, sa.1, ss.24-28, 2025 (SCI-Expanded, Scopus)
2024
202410. The Heterogeneous Syndrome of Noninfectious Causes of Persistent Fever in Neutropenic Patients With Hematologic Malignancy: Another Opportunity for Stewardship?
Aslan A. T., AKOVA M., Kontoyiannis D. P.
CLINICAL INFECTIOUS DISEASES
, cilt.79, ss.1333-1337, 2024 (SCI-Expanded, Scopus)
2024
202411. Hospital-acquired bloodstream infections in critically ill cirrhotic patients: a post-hoc analysis of the EUROBACT-2 international cohort study
Wozniak H., Tabah A., Barbier F., Ruckly S., Loiodice A., AKOVA M., et al.
ANNALS OF INTENSIVE CARE
, cilt.14, sa.1, 2024 (SCI-Expanded, Scopus)
2024
202412. Milestones and Momentum: Celebrating Six Years of Progress in Infectious Diseases and Clinical Microbiology (IDCM)
AKOVA M.
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY
, cilt.6, sa.4, ss.257, 2024 (ESCI, Scopus, TRDizin)
2024
202413. Scientific misconduct in infectious diseases-European Society of Clinical Microbiology and Infectious Diseases survey
Tau N., AKOVA M., Barac A., Nasim A., Righi E., Yahav D.
CLINICAL MICROBIOLOGY AND INFECTION
, cilt.30, sa.11, 2024 (SCI-Expanded, Scopus)
2024
202414. Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Stemler J., Yeghiazaryan L., Stephan C., Mohn K. G., Carcas-Sansuan A., Rodriguez E. R., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, cilt.146, 2024 (SCI-Expanded, Scopus)
2024
202415. Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study
Salmanton-Garcia J., Cornely O. A., Stemler J., Barac A., Steinmann J., Sivakova A., et al.
JOURNAL OF INFECTION
, cilt.89, sa.3, 2024 (SCI-Expanded, Scopus)
2024
202416. An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support System
TAŞ Z., METAN G., TELLİ DİZMAN G., Yavuz E., DİZDAR Ö., BÜYÜKAŞIK Y., et al.
ANTIBIOTICS-BASEL
, cilt.13, sa.9, 2024 (SCI-Expanded, Scopus)
2024
202417. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
Zhou H., Buetti N., Perez-Galera S., Bravo-Ferrer J., Gutierrez-Gutierrez B., Paniagua-Garcia M., et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.79, ss.2132-2141, 2024 (SCI-Expanded, Scopus)
2024
202418. Effect of therapeutic plasma exchange on antimicrobials in critically ill patients
Balaban U., Kara E., Kaya E. K., Özcebe O. İ., Akova M., Topeli İskit A., et al.
CRITICAL CARE
, sa.1, 2024 (SCI-Expanded, Scopus)
2024
202419. Beyond conventional dosing: tailoring antimicrobial regimens for cachexia
KILINÇ E. E., BAYRAKTAR ALKAN İ., KARA E., DEMİRKAN S. K., AKOVA M.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY
, 2024 (SCI-Expanded, Scopus)
2024
202420. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy
Royo-Cebrecos C., Laporte-Amargos J., Pena M., Ruiz-Camps I., Garcia-Vidal C., Abdala E., et al.
MICROORGANISMS
, cilt.12, sa.4, 2024 (SCI-Expanded, Scopus)
2024
202421. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Bassetti M., Giacobbe D. R., Agvald-Ohman C., AKOVA M., Alastruey-Izquierdo A., ARIKAN AKDAĞLI S., et al.
Intensive Care Medicine
, cilt.50, sa.4, ss.502-515, 2024 (SCI-Expanded, Scopus)
2024
202422. Common Problems and Solutions in the Management of Resistant Gram-Negative Bacterial Infections: Expert Opinion on Clinical Practice
Suemer S., Azap o. K. U. R. T., Ayguen G., AKALIN E. H., AKOVA M., KÖKSAL I.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
, cilt.29, sa.1, ss.1-24, 2024 (ESCI, TRDizin)
2024
202423. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)
Paniagua-García M., Bravo-Ferrer J. M., Pérez-Galera S., Kostyanev T., de Kraker M. E. A., Feifel J., et al.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
, cilt.30, sa.2, ss.223-230, 2024 (SCI-Expanded, Scopus)
2024
202424. Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients: results from a pan-European survey
Stemler J., Gavriilaki E., Hlukhareva O., Khanna N., Neofytos D., AKOVA M., et al.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE
, cilt.11, 2024 (ESCI, Scopus)
2024
202425. Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies
Aslan A. T., AKOVA M.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
, cilt.22, ss.1055-1071, 2024 (SCI-Expanded, Scopus)
2024
202426. The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections
Buetti N., Tabah A., Setti N., Ruckly S., Barbier F., AKOVA M., et al.
Intensive Care Medicine
, 2024 (SCI-Expanded, Scopus)
2024
202427. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
Teh B. W., Mikulska M., Averbuch D., de la Camara R., Hirsch H. H., AKOVA M., et al.
The Lancet Infectious Diseases
, cilt.24, sa.1, 2024 (SCI-Expanded, Scopus)
2023
202328. "Good" News from IDCM and Thanks to All Who Contributed
AKOVA M.
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY
, cilt.5, sa.4, ss.266, 2023 (ESCI, TRDizin)
2023
202329. The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium
Poulimeneas D., Koniordou M., Kousi D., Merakou C., Kopsidas I., Tsopela G. C., et al.
VACCINES
, cilt.11, sa.12, 2023 (SCI-Expanded, Scopus)
2023
202330. Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
Tavukcuoglu E., Yanik H., Parveen M., Uluturk S., DURUSU TANRIÖVER M., İNKAYA A. Ç., et al.
Scientific Reports
, cilt.13, sa.1, 2023 (SCI-Expanded, Scopus)
2023
202331. Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)
Neuhann J. M., Stemler J., Carcas A. J., Frías-Iniesta J., AKOVA M., Bethe U., et al.
Vaccine
, cilt.41, sa.48, ss.7166-7175, 2023 (SCI-Expanded, Scopus)
2023
202332. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study
ASLAN A. T., Tabah A., KÖYLÜ B., Kalem A. K., AKSOY F., Erol Ç., et al.
The Journal of antimicrobial chemotherapy
, cilt.78, sa.7, ss.1757-1768, 2023 (SCI-Expanded, Scopus)
2023
202333. VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe
Salmanton-García J., Wipfler P., Valle-Simón P., Merakou C., Kopsidas I., Bethe U., et al.
Vaccine
, cilt.41, sa.26, ss.3915-3922, 2023 (SCI-Expanded, Scopus)
2023
202334. Duration of antibiotic treatment and timing of oral switching for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians
Isler B., Aslan A. T., BENLİ B. S., Paterson D. L., Daneman N., Fowler R., et al.
International Journal of Antimicrobial Agents
, cilt.61, sa.6, 2023 (SCI-Expanded, Scopus)
2023
202335. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
Hoenigl M., Salmanton-García J., Egger M., Gangneux J., Bicanic T., ARIKAN AKDAĞLI S., et al.
The Lancet Infectious Diseases
, cilt.23, sa.6, ss.751-761, 2023 (SCI-Expanded, Scopus)
2023
202336. Q Fever Endocarditis-Associated Immune Complex-Mediated Proliferative Glomerulonephritis: Fourth Case from Türkiye Q Ateşi Endokarditi İlişkili İmmün Kompleks Aracılı Proliferatif Glomerülonefrit: Türkiye’den Dördüncü Olgu
Ismayilov R., Acar B. N., KAPAR B., ERDUT A., ÖZDEDE M., Sağlam A., et al.
Mikrobiyoloji bulteni
, cilt.57, sa.2, ss.293-300, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202337. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)
Pérez-Galera S., Bravo-Ferrer J. M., Paniagua M., Kostyanev T., de Kraker M. E., Feifel J., et al.
eClinicalMedicine
, cilt.57, 2023 (SCI-Expanded, Scopus)
2023
202338. Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study)
Pascale R., Toschi A., Aslan A. T., Massaro G., Maccaro A., Fabbricatore D., et al.
International Journal of Antimicrobial Agents
, cilt.61, sa.3, 2023 (SCI-Expanded, Scopus)
2023
202339. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
Tabah A., Buetti N., Staiquly Q., Ruckly S., AKOVA M., ASLAN A. T., et al.
Intensive care medicine
, cilt.49, sa.2, ss.178-190, 2023 (SCI-Expanded, Scopus)
2023
202340. Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints
Isler B., Vatansever C., Özer B., ÇINAR G., ASLAN A. T., Falconer C., et al.
Infectious Diseases
, cilt.55, sa.9, ss.607-613, 2023 (SCI-Expanded, Scopus)
2023
202341. Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit
Argyropoulos C. D., Leckler J., Salmanton-García J., Constantinou M., Alexandrou A., Themistocleous S., et al.
JMIR Public Health and Surveillance
, cilt.9, 2023 (SCI-Expanded, SSCI, Scopus)
2023
202342. Knowledge and Attitudes of Turkish Physicians towards Human Monkeypox Disease and Related Vaccination: A Cross-Sectional Study
ŞAHİN T. K., ERUL E., AKSUN M. S., SÖNMEZER M. Ç., ÜNAL S., AKOVA M.
Vaccines
, cilt.11, sa.1, 2023 (SCI-Expanded, Scopus)
2022
202243. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia
Bergeron A., Mikulska M., De Greef J., Bondeelle L., Franquet T., Herrmann J., et al.
The Lancet Infectious Diseases
, cilt.22, sa.12, 2022 (SCI-Expanded, Scopus)
2022
202244. Foreword
Pagliuca A., AKOVA M.
The Journal of antimicrobial chemotherapy
, cilt.77, sa.2, 2022 (SCI-Expanded, Scopus)
2022
202245. Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections
Isler B., Aslan A. T., AKOVA M., Harris P., Paterson D. L.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
, cilt.20, sa.11, ss.1389-1400, 2022 (SCI-Expanded, Scopus)
2022
202246. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
Royo-Cebrecos C., Laporte-Amargos J., Pena M., Ruiz-Camps I., Puerta-Alcalde P., Abdala E., et al.
PATHOGENS
, cilt.11, sa.10, 2022 (SCI-Expanded, Scopus)
2022
202247. Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022
Canton R., AKOVA M., Langfeld K., Torumkuney D.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.77, ss.2-9, 2022 (SCI-Expanded, Scopus)
2022
202248. Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates
Isler B., Vatansever C., Ozer B., ÇINAR G., ASLAN A. T., Stewart A., et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
, cilt.104, sa.1, 2022 (SCI-Expanded, Scopus)
2022
202249. Piperacillin-Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?
Aslan A. T., Akova M.
HEALTHCARE
, cilt.10, sa.8, 2022 (SCI-Expanded, SSCI, Scopus)
2022
202250. VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
Salmanton-García J., Stewart F. A., Heringer S., Koniordou M., Álvarez-Barco E., Argyropoulos C. D., et al.
Vaccine
, cilt.40, sa.31, ss.4090-4097, 2022 (SCI-Expanded, Scopus)
2022
202251. Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey
SÖNMEZER M. Ç., TELLİ DİZMAN G., Erul E., ŞAHİN T. K., SARICAOĞLU T., Alp A., et al.
VACCINES
, cilt.10, sa.7, 2022 (SCI-Expanded, Scopus)
2022
202252. COVID-19 vaccine booster strategy: striving for best practice
DURUSU TANRIÖVER M., AKOVA M.
LANCET GLOBAL HEALTH
, cilt.10, sa.6, 2022 (SCI-Expanded, SSCI, Scopus)
2022
202253. Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?
Metan G., UZUN Ö., Dizman G., SÖNMEZER M. Ç., İNKAYA A. Ç., HAZIROLAN G., et al.
Infection control and hospital epidemiology
, cilt.43, sa.6, ss.802-804, 2022 (SCI-Expanded, Scopus)
2022
202254. Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting
Isler B., Ozer B., ÇINAR G., ASLAN A. T., Vatansever C., Falconer C., et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
, cilt.41, sa.5, ss.841-847, 2022 (SCI-Expanded, Scopus)
2022
202255. Barriers Against Hepatitis B Vaccination in High-Risk Adults: A Cross-Sectional Study
ASLAN A. T., ŞAŞMAZER B., AYAR Y., Duran Z. C., AKOVA M.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.5, ss.427-436, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202256. The ESCMID ethics advisory committee (EEAC): purpose and challenges Comment
Righi E., Yahav D., AKOVA M., Nasim A., Barac A.
CLINICAL MICROBIOLOGY AND INFECTION
, cilt.28, sa.4, ss.470-471, 2022 (SCI-Expanded, Scopus)
2022
202257. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia
Albasanz-Puig A., Dura-Miralles X., Laporte-Amargos J., Mussetti A., Ruiz-Camps I., Puerta-Alcalde P., et al.
MICROORGANISMS
, cilt.10, sa.4, 2022 (SCI-Expanded, Scopus)
2022
202258. A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting.
Aslan A. T., Kırbaş E., Sancak B., Tanrıverdi E. S., Otlu B., Gürsoy N. C., et al.
International journal of antimicrobial agents
, cilt.59, ss.106554, 2022 (SCI-Expanded, Scopus)
2022
202259. The Role of Colistin in the Era of New beta-Lactam/beta-Lactamase Inhibitor Combinations
Aslan A. T., AKOVA M.
ANTIBIOTICS-BASEL
, cilt.11, sa.2, 2022 (SCI-Expanded, Scopus)
2022
202260. Voriconazole Therapeutic Drug Level Monitoring: A University Hospital Experience
KARA E., BAKIR EKİNCİ P., METAN G., EKİNCİOĞLU A., PINAR A., AKOVA M., et al.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
, cilt.27, sa.1, ss.183-188, 2022 (ESCI, TRDizin)
2021
202161. CoronaVac efficacy data from Turkey – Authors' reply
DURUSU TANRIÖVER M., Doğanay H. L., ÜNAL S., AKOVA M.
The Lancet
, cilt.398, sa.10314, ss.1874, 2021 (SCI-Expanded, Scopus)
2021
202162. Untitled reply
Tanriover M. D., Doganay H. L., ÜNAL S., AKOVA M.
LANCET
, cilt.398, sa.10314, ss.1874, 2021 (SCI-Expanded, Scopus)
2021
202163. Implementation of Pharmacist-Driven Antifungal Stewardship Program in a Tertiary Care Hospital
KARA E., METAN G., Bayraktar-Ekincioglu A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., DEMİRKAZIK F., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.65, sa.9, 2021 (SCI-Expanded, Scopus)
2021
202164. Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury
ASLAN A. T., Pashayev T., DAĞ O., AKOVA M.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
, cilt.40, sa.9, ss.1953-1961, 2021 (SCI-Expanded, Scopus)
2021
202165. Etiology and prevalence of ESBLs in adult community-onset urinary tract infections in East China: A prospective multicenter study
Quan J., Dai H., Liao W., Zhao D., Shi Q., Zhang L., et al.
JOURNAL OF INFECTION
, cilt.83, sa.2, ss.175-181, 2021 (SCI-Expanded, Scopus)
2021
202166. Expect the unexpected: fungemia caused by uncommon Candida species in a Turkish University Hospital
Özyavuz Alp Ş., Gülmez Kıvanç D., Kardaş R. C., Karahan G., Taş Z., Gürsoy G., et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
, cilt.40, sa.7, ss.1539-1545, 2021 (SCI-Expanded, Scopus)
2021
202167. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
DURUSU TANRIÖVER M., Doganay H. L., AKOVA M., Guner H. R., Azap A., AKHAN S., et al.
LANCET
, cilt.398, sa.10296, ss.213-222, 2021 (SCI-Expanded, Scopus)
2021
202168. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
AKOVA M., ÜNAL S.
TRIALS
, cilt.22, sa.1, 2021 (SCI-Expanded, Scopus)
2021
202169. Persistent dermal lesions in a patient with previous history of visceral leishmaniasis
Jaiteh M. B., İNKAYA A. Ç., ÜNER A., ELÇİN G., ERGÜVEN S., KURTULAN O., et al.
PARASITOLOGY INTERNATIONAL
, cilt.80, 2021 (SCI-Expanded, Scopus)
2021
202170. Pulmonary nocardiosis caused by Nocardia abscessus mimicking pulmonary thromboembolism in a patient with atypical anti-glomerular basement membrane glomerulonephritis
Ismayilov R., Koray N., İNAL N., TELLİ DİZMAN G., HAZIROLAN G., DURUSU TANRIÖVER M., et al.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.69, sa.2, ss.237-241, 2021 (ESCI, Scopus, TRDizin)
2021
202171. Effects of Cytochrome p450 (CYP) 2C19 Genetic Polymorphisms on Voriconazole Serum Levels: A Report of Two Cases
TAŞ Z., KARA E., DEĞER O., İspirli M., METAN G., BABAOĞLU M. Ö., et al.
Mediterranean Journal of Infection, Microbes and Antimicrobials
, cilt.10, 2021 (Scopus)
2020
202072. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
De Bus L., Depuydt P., Steen J., Dhaese S., De Smet K., Tabah A., et al.
INTENSIVE CARE MEDICINE
, cilt.46, sa.7, ss.1404-1417, 2020 (SCI-Expanded, Scopus)
2020
202073. Fungal infections of the skin and soft tissue
DOĞAN GÜNAYDIN S., ARIKAN AKDAĞLI S., AKOVA M.
CURRENT OPINION IN INFECTIOUS DISEASES
, cilt.33, sa.2, ss.130-136, 2020 (SCI-Expanded, Scopus)
2020
202074. Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network
Rello J., Sarda C., Mokart D., Arvaniti K., AKOVA M., Tabah A., et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
, cilt.39, sa.2, ss.385-392, 2020 (SCI-Expanded, Scopus)
2020
202075. Understanding resistance in Pseudomonas
Dimopoulos G., AKOVA M., Rello J., Poulakou G.
INTENSIVE CARE MEDICINE
, cilt.46, sa.2, ss.350-352, 2020 (SCI-Expanded, Scopus)
2019
201976. Splenic Actinomycosis in a Patient with Chronic Granulomatous Disease: A Case Report and Review of the Literature
AYAZ Ç. M., Hasanlı N., Demirci Duarte S., HAZIROLAN G., İNKAYA A. Ç., ÇİFTÇİ T. T., et al.
Infectious Diseases and Clinical Microbiology , cilt.1, sa.3, ss.158-164, 2019 (TRDizin)
2019
201977. Ultrastructural evaluation of urine alkalinization versus hydration on colistin-induced nephrotoxicity
Korucu B., Unal I., Pekcan M., İNKAYA A. Ç., Yeter H. H., ÇETİNKAYA M. A., et al.
Human and Experimental Toxicology
, cilt.38, sa.12, ss.1366-1377, 2019 (SCI-Expanded, Scopus)
2019
201978. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Cornely O. A., Alastruey-Izquierdo A., Arenz D., Chen S. C. A., Dannaoui E., Hochhegger B., et al.
LANCET INFECTIOUS DISEASES
, cilt.19, sa.12, 2019 (SCI-Expanded, Scopus)
2019
201979. Extended spectrum beta-lactamase producing enterobacteriaceae: carbapenem sparing options
ASLAN A. T., AKOVA M.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
, 2019 (SCI-Expanded, Scopus)
2019
201980. Dual Role of gnaA in Antibiotic Resistance and Virulence in Acinetobacter baumannii
Xu Q., Chen T., Yan B., Zhang L., Pi B., Yang Y., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.63, sa.10, 2019 (SCI-Expanded, Scopus)
2019
201981. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study
Albasanz-Puig A., Gudiol C., Parody R., Tebe C., AKOVA M., Araos R., et al.
BMJ OPEN
, cilt.9, sa.5, 2019 (SCI-Expanded, Scopus)
2019
201982. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project
Bassetti M., Scudeller L., Giacobbe D. R., Lamoth F., Righi E., Zuccaro V., et al.
MYCOSES
, cilt.62, sa.4, ss.310-319, 2019 (SCI-Expanded, Scopus)
2019
201983. Immigrants as donors and transplant recipients: specific considerations
Poulakou G., Len O., AKOVA M.
INTENSIVE CARE MEDICINE
, cilt.45, sa.3, ss.401-403, 2019 (SCI-Expanded, Scopus)
2018
201884. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Scheuerman O., Schechner V., Carmeli Y., Gutierrez-Gutierrez B., Calbo E., Almirante B., et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
, cilt.39, sa.6, ss.660-667, 2018 (SCI-Expanded, Scopus)
2018
201885. Neuroinvasive Listeriosis Could Petechial Hemorrhages be a Diagnostic Clue?
Diker S., OKAR S., Mehdikhanova L., ARSAVA E. M., KURNE A., CEVIK I. U., et al.
NEUROLOGIST
, cilt.23, sa.3, ss.86-91, 2018 (SCI-Expanded, Scopus)
2018
201886. Acinetobacter baumannii Infection and Colonization in the Intensive Care Unit: Risk Factors, Transmission Routes, and Transmission Dynamics
KIZILARSLANOĞLU M. C., Ergonul O., Cetinkaya-Sardan Y., AKOVA M.
KLIMIK JOURNAL
, cilt.31, sa.1, ss.20-29, 2018 (ESCI, Scopus, TRDizin)
2018
201887. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance
De Waele J. J., AKOVA M., Antonelli M., Canton R., Carlet J., De Backer D., et al.
INTENSIVE CARE MEDICINE
, cilt.44, sa.2, ss.189-196, 2018 (SCI-Expanded, Scopus)
2018
201888. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
Mikulska M., Averbuch D., Tissot F., Cordonnier C., AKOVA M., Calandra T., et al.
JOURNAL OF INFECTION
, cilt.76, sa.1, ss.20-37, 2018 (SCI-Expanded, Scopus)
2017
201789. Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
Harris P. N. A., Pezzani M. D., Gutierrez-Gutierrez B., Viale P., Hsueh P., Ruiz-Garbajosa P., et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
, cilt.50, sa.5, ss.664-672, 2017 (SCI-Expanded, Scopus)
2017
201790. Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
Raquel Palacios-Baena Z., Gutierrez-Gutierrez B., Calbo E., Almirante B., Viale P., Oliver A., et al.
CLINICAL INFECTIOUS DISEASES
, cilt.65, sa.10, ss.1615-1623, 2017 (SCI-Expanded, Scopus)
2017
201791. Bacteremic and non-bacteremic pneumonia caused by Acinetobacter baumannii in ICUs of South China: A Clinical and Microbiological Study
Tan Y., Zhou K., Tang X., Kudinha T., Wang L., Guo Z., et al.
SCIENTIFIC REPORTS
, cilt.7, 2017 (SCI-Expanded, Scopus)
2017
201792. Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia
Gudiol C., Royo-Cebrecos C., Abdala E., AKOVA M., Alvarez R., Maestro-de la Calle G., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.61, sa.8, 2017 (SCI-Expanded, Scopus)
2017
201793. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Gutierrez-Gutierrez B., Salamanca E., de Cueto M., Hsueh P., Viale P., Ramon Pano-Pardo J., et al.
LANCET INFECTIOUS DISEASES
, cilt.17, sa.7, ss.726-734, 2017 (SCI-Expanded, Scopus)
2017
201794. An overview on severe infections in Europe
Dimopoulos G., AKOVA M.
INTENSIVE CARE MEDICINE
, cilt.43, sa.5, ss.686-689, 2017 (SCI-Expanded, Scopus)
2017
201795. MP246IN VIVO EVALUATION OF PROTECTIVE EFFECT OF HYDRATION WITH SODIUM CHLORIDE VERSUS URINE ALKALINISATION ON COLISTIN INDUCED NEPHROTOXICITY IN RATS
KORUCU B., ÜNAL ı., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., İNKAYA A. Ç., et al.
Nephrology Dialysis Transplantation , cilt.32, ss.516-517, 2017 (SCI-Expanded, Scopus)
2017
201796. IN VIVO EVALUATION OF PROTECTIVE EFFECT OF HYDRATION WITH SODIUM CHLORIDE VERSUS URINE ALKALINISATION ON COLISTIN INDUCED NEPHROTOXICITY IN RATS
Korucu B., Unal I., Pekcan M., ÇETİNKAYA M. A., KAYMAZ F. F., İNKAYA A. Ç., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION
, cilt.32, 2017 (SCI-Expanded, Scopus)
2017
201797. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study
Quan J., Li X., Chen Y., Jiang Y., Zhou Z., Zhang H., et al.
LANCET INFECTIOUS DISEASES
, cilt.17, sa.4, ss.400-410, 2017 (SCI-Expanded, Scopus)
2017
201798. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extendedspectrum- beta-lactamase-producing Enterobacteriaceae
Raquel Palacios-Baena Z., Gutierrez-Gutierrez B., De Cueto M., Viale P., Venditti M., Hernandez-Torres A., et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.72, sa.3, ss.906-913, 2017 (SCI-Expanded, Scopus)
2017
201799. Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation
Alp Ş., AKOVA M.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
, cilt.9, 2017 (SCI-Expanded, Scopus)
2017
2017100. Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccination
Blasi F., AKOVA M., Bonanni P., Dartois N., Sauty E., Webber C., et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE
, cilt.37, ss.13-18, 2017 (SCI-Expanded, Scopus)
2017
2017101. Antimicrobial Stewardship in Turkey
Ergonul O., Can F., AKOVA M.
ANTIMICROBIAL STEWARDSHIP
, cilt.2, ss.331-333, 2017 (SCI-Expanded)
2017
2017102. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China
Quan J., Zhao D., Liu L., Chen Y., Zhou J., Jiang Y., et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.72, sa.1, ss.273-280, 2017 (SCI-Expanded, Scopus)
2017
2017103. Antimicrobial Stewardship in Hematology Patients
AKOVA M.
ANTIMICROBIAL STEWARDSHIP
, cilt.2, ss.205-217, 2017 (SCI-Expanded)
2016
2016104. Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done?
METAN G., AKOVA M.
CURRENT OPINION IN INFECTIOUS DISEASES
, cilt.29, sa.6, ss.555-560, 2016 (SCI-Expanded, Scopus)
2016
2016105. Evaluation of PNA-FISH Method for Direct Identification of Candida Species in Blood Culture Samples and Its Potential Impact on Guidance of Antifungal Therapy
Dogan O., İNKAYA A. Ç., Gulmez D., UZUN Ö., AKOVA M., ARIKAN AKDAĞLI S.
MIKROBIYOLOJI BULTENI
, cilt.50, sa.4, ss.580-589, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
2016106. A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Gutierrez-Gutierrez B., Salamanca E., de Cueto M., Hsueh P., Viale P., Ramon Pano-Pardo J., et al.
MAYO CLINIC PROCEEDINGS
, cilt.91, sa.10, ss.1362-1371, 2016 (SCI-Expanded, Scopus)
2016
2016107. Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013
Zarakolu P., Eser O. K., Aladag E., Al-Zahranı I. A., Day K. M., Atmaca O., et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
, cilt.85, ss.466-470, 2016 (SCI-Expanded, Scopus)
2016
2016108. A Multinational, Preregistered Cohort Study of beta-Lactam/beta-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae
Gutierrez-Gutierrez B., Perez-Galera S., Salamanca E., de Cueto M., Calbo E., Almirante B., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.60, sa.7, ss.4159-4169, 2016 (SCI-Expanded, Scopus)
2016
2016109. Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Gutierrez-Gutierrez B., Bonomo R. A., Carmeli Y., Paterson D. L., Almirante B., Martinez-Martinez L., et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.71, sa.6, ss.1672-1680, 2016 (SCI-Expanded, Scopus)
2016
2016110. Epidemiology of antimicrobial resistance in bloodstream infections
AKOVA M.
VIRULENCE
, cilt.7, sa.3, ss.252-266, 2016 (SCI-Expanded, Scopus)
2016
2016111. Prospective Evaluation of Infection Episodes in Cancer Patients in a Tertiary Care Academic Center: Microbiological Features and Risk Factors for Mortality
ÇALIK BAŞARAN N., Karaagaoglu E., Hascelik G., DURUSU TANRIÖVER M., AKOVA M.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.4, ss.311-319, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
2016112. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Abdul-Aziz M. H., Lipman J., AKOVA M., Bassetti M., De Waele J. J., Dimopoulos G., et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.71, sa.1, ss.196-207, 2016 (SCI-Expanded, Scopus)
2015
2015113. Task force on management and prevention of Acinetobacter baumannii infections in the ICU
Garnacho-Montero J., Dimopoulos G., Poulakou G., AKOVA M., Miguel Cisneros J., De Waele J., et al.
INTENSIVE CARE MEDICINE
, cilt.41, sa.12, ss.2057-2075, 2015 (SCI-Expanded, Scopus)
2015
2015114. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease
Torres A., Blasi F., Dartois N., AKOVA M.
THORAX
, cilt.70, sa.10, ss.984-989, 2015 (SCI-Expanded, Scopus)
2015
2015115. Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010
Alp S., ARIKAN-AKDAGLI S., GULMEZ D., ASCIOGLU S., UZUN Ö., AKOVA M.
MYCOSES
, cilt.58, sa.8, ss.498-505, 2015 (SCI-Expanded, Scopus)
2015
2015116. Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey
Zarakolu P., Day K. M., SIDJABAT H. E., KAMOLVIT W., Lanyon C. V., Cummings S. P., et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
, cilt.34, sa.3, ss.519-525, 2015 (SCI-Expanded, Scopus)
2015
2015117. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
Sinnollareddy M. G., Roberts J. A., Lipman J., AKOVA M., Bassetti M., De Waele J. J., et al.
CRITICAL CARE
, cilt.19, 2015 (SCI-Expanded, Scopus)
2015
2015118. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies
Kara O., Zarakolu P., AŞÇIOĞLU HAYRAN S., ETGÜL S., Uz B., BÜYÜKAŞIK Y., et al.
INFECTIOUS DISEASES
, cilt.47, sa.10, ss.686-693, 2015 (SCI-Expanded, Scopus)
2015
2015119. Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4)
Boga C., Bolaman Z., Cagirgan S., Karadogan I., ÖZCAN M. A., ÖZKALEMKAŞ F., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.32, sa.2, ss.100-117, 2015 (SCI-Expanded, Scopus, TRDizin)
2014
2014120. Molecular characterization of NDM-1-producing Acinetobacter pittii isolated from Turkey in 2006
Roca I., MOSQUEDA N., ALTUN B., ESPİNAL P., AKOVA M., VİLA J.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.69, sa.12, ss.3437-3438, 2014 (SCI-Expanded, Scopus)
2014
2014121. Impact of Loading Doses on the Time to Adequate Predicted Beta-Lactam Concentrations in Prolonged and Continuous Infusion Dosing Schemes Reply
Roberts J. A., Paul S. K., AKOVA M., Bassetti M., De Waele J. J., Dimopoulos G., et al.
CLINICAL INFECTIOUS DISEASES
, cilt.59, sa.6, ss.907-908, 2014 (SCI-Expanded, Scopus)
2014
2014122. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients
Mikulska M., Viscoli C., Orasch C., Livermore D. M., Averbuch D., Cordonnier C., et al.
JOURNAL OF INFECTION
, cilt.68, sa.4, ss.321-331, 2014 (SCI-Expanded, Scopus)
2014
2014123. DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current beta-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Roberts J. A., Paul S. K., AKOVA M., Bassetti M., De Waele J. J., Dimopoulos G., et al.
CLINICAL INFECTIOUS DISEASES
, cilt.58, sa.8, ss.1072-1083, 2014 (SCI-Expanded, Scopus)
2014
2014124. Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria
Petrosillo N., GIANNELLA M., ANTONELLI M., ANTONINI M., BARSIC B., BELANCIC L., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.58, sa.2, ss.851-858, 2014 (SCI-Expanded, Scopus)
2014
2014125. The risk of pneumococcal disease in lung diseases and the importance of adult vaccination in the treatment of adult pneumococcal disease in lung diseases
SAYINER A., MİRİCİ A., ÇİLLİ A., Uzaslan E., AKOVA M., ÖZHAN M. H., et al.
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
, cilt.62, sa.2, ss.154-159, 2014 (ESCI, Scopus, TRDizin)
2014
2014126. Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
Blot S., Koulenti D., AKOVA M., Bassetti M., De Waele J. J., Dimopoulos G., et al.
CRITICAL CARE
, cilt.18, sa.3, 2014 (SCI-Expanded, Scopus)
2013
2013127. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)
Averbuch D., Cordonnier C., Livermore D. M., Mikulska M., Orasch C., Viscoli C., et al.
HAEMATOLOGICA
, cilt.98, sa.12, ss.1836-1847, 2013 (SCI-Expanded, Scopus)
2013
2013128. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
Averbuch D., Orasch C., Cordonnier C., Livermore D. M., Mikulska M., Viscoli C., et al.
HAEMATOLOGICA
, cilt.98, sa.12, ss.1826-1835, 2013 (SCI-Expanded, Scopus)
2013
2013129. A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease
Ben-Ami R., Halaburda K., Klyasova G., Metan G., Torosian T., AKOVA M.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.68, ss.25-33, 2013 (SCI-Expanded, Scopus)
2013
2013130. Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV
Kern W. V., Marchetti O., Drgona L., AKAN H., Aoun M., Akova M., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.31, sa.9, ss.1149-1156, 2013 (SCI-Expanded, Scopus)
2013
2013131. Management of febrile neutropenia in the era of bacterial resistance
ÖZYAVUZ ALP Ş., AKOVA M.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE
, cilt.1, sa.1, ss.37-43, 2013 (ESCI, Scopus)
2011
2011132. Pneumonia Caused by Fusobacterium necrophorum Is Lemierre SyndromeStill Current
GÜLMEZ KIVANÇ D., ÖZYAVUZ ALP Ş., TOPELİ İSKİT A., AKOVA M., HASÇELİK A. G.
Mikrobiyoloji Bulteni , cilt.45, ss.729-734, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011133. Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate
Kan B., Altay M. A., Tasar F., AKOVA M.
LASERS IN MEDICAL SCIENCE
, cilt.26, sa.5, ss.569-575, 2011 (SCI-Expanded, Scopus)
2011
2011134. Comparative Evaluation of In Vitro Activities of Carbapenemes Against Gram-Negative Pathogens: Turkish Data of COMPACT Study
KORTEN V., Soyletir G., YALÇIN A. N., Ogunc D., Dokuzoguz B., Esener H., et al.
MIKROBIYOLOJI BULTENI
, cilt.45, sa.2, ss.197-209, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011135. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
Pagano L., AKOVA M., Dimopoulos G., Herbrecht R., Drgona L., Blijlevens N.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
, cilt.66, 2011 (SCI-Expanded, Scopus)
2011
2011136. A novel fungal pathogen under the spotlight - Acremonium spp. associated fungaemia in an immunocompetent host
PÜRNAK T., Beyazit Y., Sahin G. O., Shorbagi A., AKOVA M.
MYCOSES
, cilt.54, sa.1, ss.78-80, 2011 (SCI-Expanded, Scopus)
2008
2008137. The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study
Kucukardali Y., ÖNCÜL M. O., Cavuslu S., Danaci M., Calangu S., Erdem H., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, cilt.12, sa.1, ss.71-79, 2008 (SCI-Expanded, Scopus)
2007
2007138. TİGESİKLİN
ÇALIK BAŞARAN N., AKOVA M.
ANKEM Dergisi , cilt.21, sa.2, ss.29-33, 2007 (TRDizin)
2007
2007139. The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates-of Pseudomonas aeruginosa
ZARAKOLU P., METAN G., AYDİN N. G., ALTUN B., HASÇELİK A. G., AKOVA M.
MIKROBIYOLOJI BULTENI
, cilt.41, sa.3, ss.363-367, 2007 (SCI-Expanded, Scopus, TRDizin)
2007
2007140. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
Cornaglia G., Akova M., Amicosante G., Canton R., Cauda R., Docquier J., et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
, cilt.29, sa.4, ss.380-388, 2007 (SCI-Expanded, Scopus)
2006
2006141. Emerging problem pathogens: A review of resistance patterns over time
Akova M.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, cilt.10, 2006 (SCI-Expanded, Scopus)
2006
2006142. Clinical research in the lay press: Irresponsible journalism raises a huge dose of doubt
Anaissie E. J., Segal B. H., Graybill J. R., Arndt C., Perfect J. R., Kleinberg M., et al.
CLINICAL INFECTIOUS DISEASES
, cilt.43, sa.8, ss.1031-1039, 2006 (SCI-Expanded, Scopus)
2006
2006143. Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997-2001)
Guven G., Uzun O., CAKIR B., Akova M., Unal S.
SUPPORTIVE CARE IN CANCER
, cilt.14, sa.1, ss.52-55, 2006 (SCI-Expanded, Scopus)
2005
2005144. Fungal Infections in Neutropenic Patients
AKOVA M.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
, cilt.26, 2005 (SCI-Expanded, Scopus)
2003
2003145. Çeşitli Hastanelerde İzole Edilen Stafilokok Suşlarının Fusidik Asit ve Sık Kullanılan Diğer Antibiyotiklere Duyarlılıkları
ALTUN B., KOCAGÖZ A. S., HASÇELİK A. G., UZUN Ö., AKOVA M., ÜNAL S.
Türk Mikrobiyoloji Cemiyeti Dergisi , cilt.33, ss.8-11, 2003 (TRDizin)
2002
2002146. In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey
Kocagoz S., Akova M., Altun B., Gur D., Hascelik G.
CLINICAL MICROBIOLOGY AND INFECTION
, cilt.8, sa.4, ss.240-242, 2002 (SCI-Expanded, Scopus)
2000
2000147. Analysis of a mini-outbreak of methicillin-resistant Staphylococcus aureus in a surgical ward by using arbitrarily primed-polymerase chain reaction
CETINKAYA Y., KOCAGOZ S., HAYRAN M., Uzun O., Akova M., GURSU G., et al.
JOURNAL OF CHEMOTHERAPY
, cilt.12, sa.2, ss.138-144, 2000 (SCI-Expanded, Scopus)
1999
1999148. Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis
GUR D., KOCAGOZ S., Akova M., Unal S.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.43, sa.9, ss.2337, 1999 (SCI-Expanded, Scopus)
1998
1998149. Primary cutaneous aspergillosis in human immunodeficiency virus-infected patients: Two cases and review
ARIKAN S., Uzun O., CETINKAYA Y., KOCAGOZ S., Akova M., Unal S.
CLINICAL INFECTIOUS DISEASES
, cilt.27, sa.3, ss.641-643, 1998 (SCI-Expanded, Scopus)
1998
1998150. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis
ARIKAN S., AKOVA M., HAYRAN M., OZDEMIR O., ERMAN M., GUR D., et al.
CLINICAL INFECTIOUS DISEASES
, cilt.26, sa.4, ss.903-908, 1998 (SCI-Expanded, Scopus)
1997
1997151. A randomized multicenter comparative study of cefepime and ceftazidime in combination with amikacin in the treatment of patients with fever and neutropenia
ERMAN M., Akan H., KORTEN V., Ferhanoǧlu B., UZUN Ö., ÜNAL S., et al.
Clinical Infectious Diseases
, cilt.25, sa.2, ss.463, 1997 (SCI-Expanded, Scopus)
1997
1997152. Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients
ARIKAN S., Gur D., AKOVA M.
MYCOSES
, cilt.40, ss.291-296, 1997 (SCI-Expanded, Scopus)
1997
1997153. Native valve endocarditis with persistent embolization due to Neisseria mucosa [4]
Tuncer S., HAYRAN K. M., Akan O., Gur D., AKOVA M., ÜNAL S.
Clinical Microbiology and Infection
, cilt.3, sa.1, ss.137-139, 1997 (Scopus)
1996
1996154. Treatment of enteric fever with pefloxacin for 7 days versus 5 days: A randomized clinical trial
Unal S., HAYRAN M., TUNCER S., GUR D., Uzun O., Akova M., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.40, sa.12, ss.2898-2900, 1996 (SCI-Expanded, Scopus)
1996
1996155. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections
Akova M., Ozcebe O. İ., Gullu I., Unal S., GUR D., AKALIN S., et al.
JOURNAL OF CHEMOTHERAPY
, cilt.8, sa.4, ss.284-289, 1996 (SCI-Expanded, Scopus)
1994
1994156. Efficacy of a three day course of azithromycin in the treatment of community acquired pneumococcal pneumonia Preliminary report
UZUN Ö., Hayran M., AKOVA M., Akalın E.
Journal of Chemotherapy , cilt.6, sa.1, ss.53-57, 1994 (Scopus)
1993
1993157. QUINOLONES IN TREATMENT OF HUMAN BRUCELLOSIS - COMPARATIVE TRIAL OF OFLOXACIN-RIFAMPIN VERSUS DOXYCYCLINE-RIFAMPIN
AKOVA M., UZUN O., AKALIN H., HAYRAN M., UNAL S., GUR D.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.37, sa.9, ss.1831-1834, 1993 (SCI-Expanded, Scopus)
1993
1993158. OXA-11, AN EXTENDED-SPECTRUM VARIANT OF OXA-10 (PSE-2) BETA-LACTAMASE FROM PSEUDOMONAS-AERUGINOSA
HALL L., LIVERMORE D., GUR D., AKOVA M., AKALIN H.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, sa.8, ss.1637-1644, 1993 (SCI-Expanded, Scopus)
1991
1991159. Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole
AKOVA M., Akalin H., UZUN Ö., GÜR D.
European Journal of Clinical Microbiology & Infectious Diseases
, cilt.10, sa.7, ss.598-599, 1991 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2019
20191. EARLY CESSATION OF EMPIRICAL ANTIBACTERIAL THERAPY IN HIGH-RISK FEBRILE NEUTROPENIC PATIENTS WITH FEVER OF UNKNOWN ORIGIN (FUO)
KORUCU B., İNKAYA A. Ç., ERBİL A., OKAY M., AŞÇIOĞLU S., TOKUÇOĞLU ALTUNAY H., et al.
20TH SYMPOSIUM ON INFECTIONS IN THE IMMUNOCOMPROMISED HOST, ATİNA, Yunanistan, 17 - 19 Temmuz 2019, ss.76, (Özet Bildiri)
2018
20182. Mixed fungemia within 18-years in a university hospital and antifungal susceptibility profiles of the isolates
GÜLMEZ KIVANÇ D., ÖZYAVUZ ALP Ş., GÜRSOY G., AYAZ Ç. M., DOĞAN Ö., ARIKAN AKDAĞLI S., et al.
Balkan Fungus 2018 First Balkan Conference on Medical Mycology and Mycotoxicology, Temeşvar, Romanya, 13 - 15 Eylül 2018, cilt.26, ss.70-71, (Özet Bildiri)
2018
20183. Compliance to the guideline of diagnostic tests in febrile neutropenic patients at a Turkish university hospital’
ZARAKOLU KÖŞKER I. P., AKOVA M., BÜYÜKAŞIK Y., DURUSU TANRIÖVER M., DİZDAR Ö., METAN G., et al.
20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018, (Tam Metin Bildiri)
2018
20184. Impact of effective antibiptic therapy on mortality in patients with XDR Acinetobacter baumannii bloodstream infections
ZARAKOLU KÖŞKER I. P., AKOVA M., ESER Ö., Özdede M., METAN G.
20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018, (Tam Metin Bildiri)
2018
20185. Concomitant Herpes Simplex and Cytomegalovirus Reactivations in a Mycosis Fungoides Patient under Romidepsin Treatment: A Case Report
İNKAYA A. Ç., DOĞAN GÜNAYDIN S., ÖZYAVUZ ALP Ş., AKOVA M.
20th ICHS Symposium on Infections in the Immunocompromised Host, 17 - 19 Haziran 2018, (Özet Bildiri)
2018
20186. Evaluation of 2 commercial assays for the rapid confirmation of OXA-48 carbapenemases from Klebsiella pneumoniae isolates’, P3, p.72, Athens, Greece, 2018.
ZARAKOLU KÖŞKER I. P., AKOVA M., Perry J., ASLAN A. T.
20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018, (Tam Metin Bildiri)
2017
20177. SALMONELLA GRUP D’NİN NEDEN OLDUĞU SEPTİK ARTRİT OLGUSU
KARDAŞ R. C., BIÇAKCIGİL A., ERDUT A., ÇİÇEK M., LİSTE Ü., ALTUN B., et al.
4 ULUSAL KLİNİK MİKROBİYOLOJİ KONGRESİ, Türkiye, 8 - 12 Kasım 2017, (Özet Bildiri)
2017
20178. Fungemia due to rare yeasts and antifungal susceptibility profiles in a tertiary care university center
ÖZYAVUZ ALP Ş., GÜLMEZ KIVANÇ D., AYAZ Ç. M., ARIKAN AKDAĞLI S., AKOVA M.
8th Trends in Medical Mycology, 6 - 09 Ekim 2017, (Özet Bildiri)
2017
20179. In vivo evaluation of protective effect of hydration with sodium chloride versus urine
KORUCU B., ünal ı., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., HAYRAN K. M., et al.
54th era-edta congress, 3 - 06 Haziran 2017, (Tam Metin Bildiri)
2017
201710. IN VIVO EVALUATION OF PROTECTIVE EFFECT OF HYDRATION WITH SODIUM CHLORIDE VERSUS URINE ALKALINISATION ON COLISTIN INDUCED NEPHROTOXICITY IN RATS
KORUCU B., ÜNAL I., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., İNKAYA A. Ç., et al.
54th ERA-EDTA CONGRESS, Madrid, İspanya, 3 - 06 Haziran 2017, (Özet Bildiri)
2017
201711. Can urine alkalinisation be a treatment option on colistin induced nephrotoxicity: an ultrastructural and histochemical study on rats
KORUCU B., ÜNAL I., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., HAYRAN K. M., et al.
15th International Congress of Histochemistry and Cytochemistry (ICHC 2017) in Antalya, 18 - 21 Mayıs 2017, (Özet Bildiri)
2017
201712. The changing epidemiology of candidaemia in a tertiary care university centre. P0959
ÖZYAVUZ ALP Ş., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., AKOVA M.
27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Viyana, Avusturya, 22 - 25 Nisan 2017, (Özet Bildiri)
2016
201613. Listeria rhomboensefalit Farklı yüzler farklı tarzlar
AKOVA M., GÖÇMEN R., KARLI OĞUZ H. K., MUT AŞKUN M., TOPÇUOĞLU M. A., ÜNAL ÇEVİK I., et al.
52. Ulusal Nöroloji Kongresi, Türkiye, 25 Kasım - 01 Aralık 2016
2015
201514. Levofloksasin profilaksisi alan hematolojik kanserli nötropenik hastalarda kinolon dirençli Escherichia coli sürveyansı
ETGÜL S., ZARAKOLU KÖŞKER I. P., ESER Ö., KARA Ö., BÜYÜKAŞIK Y., Akova M.
3. Ulusal Klinik Mikrobiyoloji Uzmanlık Derneği Kongresi, Türkiye, 18 - 22 Kasım 2015, (Tam Metin Bildiri)
2015
201515. Etgül S P Zarakolu Ö K Eser Ö Kara Y Büyükaşık M Akova Impact of Levofloxacin Prophylaxis LP in Acute Leukaemia AL Patients with Neutropenia in a High Quinolone Resistance Setting Proc p P1207 Copenhagen Denmark 2015
ETGÜL S., ZARAKOLU KÖŞKER I. P., AKOVA M., Kara Ö.
24th European Congress of Clinical Microbiology and Infectious Diseases, 25 - 28 Nisan 2015, (Tam Metin Bildiri)
2014
201416. Kan kültürlerinden izole edilen Candida türlerinin PNA FISH yöntemiyle hızlı tanımlanmasının konvansiyonel tanımlama yöntemleriyle uyum ve antifungal tedavinin yönlendirilmesine olası etki yönünden değerlendirilmesi
DOĞAN AYÇIK Ö., İNKAYA A. Ç., GÜLMEZ KIVANÇ D., UZUN Ö., AKOVA M., ARIKAN AKDAĞLI S.
Febril Nötropeni Klavuz Toplantısı, Ankara, Türkiye, 29 - 30 Mart 2014, (Özet Bildiri)
2013
201317. Mart 2006 Ocak 2013 yılları arasında Hacettepe Üniversitesi Erişkin Hastanesi nde küf mantarı üremesi olan hastaların dağılımı
HA Y., ARIKAN AKDAĞLI S., GÜLMEZ KIVANÇ D., DOĞAN AYÇIK Ö., AKOVA M.
10. Febril Nötropeni Simpozyumu, Ankara, Türkiye, 17 - 19 Mayıs 2013, (Özet Bildiri)
2012
201218. Epidemiology of Candida bloodstream infections and antifungal susceptibility profiles 10 year experience with 381 candidaemia episodes in a tertiary care university centre
ÖZYAVUZ ALP Ş., ARIKAN AKDAĞLI S., GÜLMEZ KIVANÇ D., AŞÇIOĞLU HAYRAN S., UZUN Ö., AKOVA M.
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Londrina, Birleşik Krallık, 31 Mart - 03 Nisan 2012, (Özet Bildiri)
2009
200919. A retrospective study comparing cefoperazone sulbactam with piperacillin tazobactam as empirical therapy for febrile neutropenia in adults with hematological disorders
bitik b., ÖZYAVUZ ALP Ş., ÇALIK BAŞARAN N., AKOVA M., UZUN Ö., ÜNAL S.
8th Congress of The European Federation of Internal Medicine, İstanbul, Türkiye, 27 - 30 Mayıs 2009, cilt.20, ss.225, (Özet Bildiri)
2008
200820. HEMATOLOJİK MALİGNİTELİ HASTALARDA KAN DOLAŞIMI İNFEKSİYONLARININ SIKLIĞI VE ETKENLERİN DAĞILIMI HACETTEPE DE DEĞİŞİMİ
ÇALIK BAŞARAN N., ÖZVEREN A., AKOVA M.
8. FEBRİL NÖTROPENİ SEMPOZYUMU, Ankara, Türkiye, 21 - 24 Şubat 2008, (Özet Bildiri)
2008
200821. KANSER HASTALARINDA FUNGEMİ GÖRÜLME SIKLIĞI HACETTEPE DENEYİMİ
ÖZVEREN A., ÇALIK BAŞARAN N., AKOVA M.
8. FEBRİL NÖTROPENİ SEMPOZYUMU, Ankara, Türkiye, 21 - 24 Şubat 2008, ss.183, (Özet Bildiri)
2005
200522. EPIDEMIOLOGY OF BACTERIAL INFECTIONS AND RISK FACTORS FOR MORTALITY IN CANCER PATIENTS
ÇALIK BAŞARAN N., KARAAĞAOĞLU A. E., HASÇELİK A. G., AKOVA M.
INTERSCIENCE CONFERENCE ON ANTİMİCROBİAL AGENTS AND CHEMOTHERAPY, Washington, Kiribati, 16 - 19 Aralık 2005, (Özet Bildiri)
1996
199623. An open study of clarithromycin in the treatment of pneumonia due to Streptococcus pneumoniae
HAYRAN M., Erman M., GUR D., Akova M., Unal S.
3rd International Conference on the Macrolides, Azalides, and Streptogramins, Lisbon, Portekiz, 24 - 26 Ocak 1996, cilt.21, ss.429-431, (Tam Metin Bildiri)
Kitaplar
2021
20211. Araştırma A. SARS-CoV-2 Faz III Aşı Çalışmaları
Dikçınar Yücesoy S. N., Özusta Ş., İNKAYA A. Ç., DURUSU TANRIÖVER M., AKOVA M., ÜNAL S.
Covıd-19 Pandemİ Raporu (20 Mart-20 Kasım 2020), Topeli İskit A, Durusu Tanrıöver M, Uzun Ö, Editör, Uzerler Matbaası, Ankara, ss.256-266, 2021
2019
20192. Kulak burun boğaz, baş boyun cerrahisinde antibiyotik kullanımı
ZARAKOLU KÖŞKER I. P., AKOVA M.
Kulak Burun Boğaz hastalıkları ve Baş Boyun Cerrahisi, Can Koç, Editör, Güneş Tıp, Ankara, ss.33-37, 2019
2017
20173. Enfektif Endokardit, Miyokardit, Perikardit
İNKAYA A. Ç., AKOVA M.
Enfeksiyon Hastalıkları ve Mikrobiyolojisi, Topçu Ayşe Willke, Söyletir Güner, Doğanay Mehmet, Editör, Nobel Tıp Kitabevleri, İstanbul, ss.951-969, 2017
2013
20134. Antibiyotik Tedavisinin Esasları
İNKAYA A. Ç., AKOVA M.
Yaşlılıkta İnfeksiyonlar, Köse Şükran, Yalçın Ata Nevzat, Erbay Rıza Hakan, Editör, Bulaşıcı Hastalıkları Önleme Derneği Yayınları, İzmir, ss.67-73, 2013
2010
20105. İNVAZİV ASPERGİLLOZİS
ÇALIK BAŞARAN N., AKOVA M.
FEBRİL NÖTROPENİ, MURAT AKOVA, HAMDİ AKAN, Editör, BİLİMSEL TIP YAYINEVİ, Ankara, ss.431-449, 2010
2008
20086. NÖTROPENİK HASTALARDA İNFEKSİYONLAR
ÇALIK BAŞARAN N., AKOVA M.
ENFEKSİYON HASTALIKLARI VE MİKROBİYOLOJİSİ, AYŞE WİLKE TOPÇU, GÜNER SÖYLETİR, MEHMET DOĞANAY, Editör, NOBEL TIP KİTABEVİ, İstanbul, ss.641-650, 2008
2007
20077. YETİŞKİNLERDE İNFLUENZA AŞILAMASI
ÇALIK BAŞARAN N., AKOVA M.
GRİP ÖNLEMLER VE TEDAVİ, MEHMET CEYHAN, Editör, MEDYA TOWERTANITIM VE YAYINCILIK HİZMETLERİ, İstanbul, ss.47-62, 2007
Desteklenen Projeler
2022 - 2024
2022 - 2024Piperasilintazobaktam ve Vankomisin kombinasyonu ile Piperasilintazobaktam ve Teikoplanin kombinasyonunun akut böbrek hasarı riski açısından karşılaştırılması Comparison of Piperacillintazobactam and Vancomycin TZPVAN with Piperacillintazobactam and Teicoplanin TZPTEI for the risk of Acute Kidney Injury CONCOMITANT
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
AKOVA M. (Yürütücü), PINAR A., KARA E.
2020 - 2022
2020 - 2022Karbapenem Dirençli Klebsiella Pneumoniae Bakteremisi Olan Hastalarda Mortalite Riskini Artıran Faktörlerinin Belirlenmesi ve Kullanılan Antibiyotik Tedavilerinin Mortalite ve Klinik Başarı Üzerine Etkilerinin Araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
AKOVA M. (Yürütücü), DAĞ O., SANCAK B., SAİN GÜVEN G., ASLAN A. T.
2020 - 2022
2020 - 2022Karbapenem Dirençli-Kolistin Dirençli Klebsiella pneumoniae ile Kan Akımı İnfeksiyonu Olan Hastaların Karbapenem Dirençli-Kolistin Duyarlı Klebsiella pneumoniae ile Kan Akımı İnfeksiyonu Olan Hastalarla 30 Günlük Kaba Mortalite Oranları Açısından Karşılaştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
AKOVA M. (Yürütücü), HAZIROLAN G., DAĞ O., KÖYLÜ B., ASLAN A. T.
2020 - 2020
2020 - 2020
COVID19 Pozitif Çocuklarda Erişkinlere Kıyasla İyi Klinik Seyir Sitokin ve Kemokin Cevaplarıyla Açıklanabilir mi?
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
ÖZSÜREKCİ Y. (Yürütücü), CEYHAN M., AKOVA M., TOPELİ İSKİT A., CENGİZ A. B., ALP A., et al.